The effects of valsartan on cognitive deficits induced by aluminum trichloride and d-galactose in mice

References

• Castellani RJ, Zhu X, Lee HG, Moreira PI, Perry G, Smith MA. Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees? Expert Rev Neurother. 2007;7:473–85.
   PubMed Web of Science ®Google Scholar
• McIlroy S, Craig D. Neurobiology and genetics of behavioural syndromes of Alzheimer's disease. Curr Alzheimer Res. 2004;1:135–42.
   PubMed Web of Science ®Google Scholar
• Hasselmo ME. The role of acetylcholine in learning and memory. Curr Opin Neurobiol. 2006;16:710–5.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao B. Natural antioxidants in prevention and management of Alzheimer's disease. Front Biosci. 2012;4:794–808.
   Google Scholar
• Kaizer RR, Correa MC, Gris LRS, da Rosa CS, Bohrer D, Morsch VM, et al. Effect of long-term exposure to aluminum on the acetylcholinesterase activity in the central nervous system and erythrocytes. Neurochem Res. 2008;33:2294–301.
   PubMed Web of Science ®Google Scholar
• Kumar A, Dogra S, Prakash A. Protective effect of curcumin (Curcuma longa), against aluminium toxicity: possible behavioral and biochemical alterations in rats. Behav Brain Res. 2009;205:384–90.
   PubMed Web of Science ®Google Scholar
• Shan Q, Lu J, Zheng Y, Li J, Zhou Z, Hu B, et al. Purple sweet potato color ameliorates cognition deficits and attenuates oxidative damage and inflammation in aging mouse brain induced by d-galactose. J Biomed Biotechnol. 2009;2009:564737.
   PubMedGoogle Scholar
• Su Y, Sun H, Fang J, Hu G, Xiao M. Brain mitochondrial dysfunction in ovariectomized mice injected with d-galactose. Neurochem Res. 2010;35:399–404.
   PubMed Web of Science ®Google Scholar
• Yoo DY, Kim W, Kim IH, Nam SM, Chung JY, Choi JH, et al. Combination effects of sodium butyrate and pyridoxine treatment on cell proliferation and neuroblast differentiation in the dentate gyrus of d-galactose-induced aging model mice. Neurochem Res. 2012;37:223–31.
   PubMed Web of Science ®Google Scholar
• Luo Y, Niu F, Sun Z, Cao W, Zhang X, Guan D, et al. Altered expression of A beta metabolism-associated molecules from d-galactose/AlCl(3) induced mouse brain. Mech Ageing Dev. 2009;130:248–52.
   PubMed Web of Science ®Google Scholar
• Xian YF, Lin ZX, Zhao M, Mao QQ, Ip SP, Che CT. Uncaria rhynchophylla ameliorates cognitive deficits induced by d-galactose in mice. Planta Med. 2011;77:1977–83.
   PubMed Web of Science ®Google Scholar
• Sun ZZ, Chen ZB, Jiang H, Li LL, Li EG, Xu Y. Alteration of A beta metabolism-related molecules in predementia induced by AlCl3 and d-galactose. Age. 2009;31:277–84.
   PubMed Web of Science ®Google Scholar
• De Bundel D, Smolders I, Vanderheyden P, Michotte Y. Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy. CNS Neurosci Ther. 2008;14:315–39.
   PubMed Web of Science ®Google Scholar
• Speth RC, Karamyan VT. The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain. Heart Fail Rev. 2008;13:299–309.
   PubMed Web of Science ®Google Scholar
• Gard PR. The role of angiotensin II in cognition and behaviour. Eur J Pharmacol. 2002;438:1–14.
   PubMed Web of Science ®Google Scholar
• Wright JW, Harding JW. The brain RAS and Alzheimer's disease. Exp Neurol. 2010;223:326–33.
   PubMed Web of Science ®Google Scholar
• Hajjar I, Keown M, Frost B. Antihypertensive agents for aging patients who are at risk for cognitive dysfunction. Curr Hypertens Rep. 2005;7:466–73.
   PubMed Web of Science ®Google Scholar
• Braszko JJ, Karwowska-Polecka W, Halicka D, Gard PR. Captopril and enalapril improve cognition and depressed mood in hypertensive patients. Basic Clin Physiol Pharmacol. 2003;14:323–43.
   PubMedGoogle Scholar
• Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, et al. Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease. FASEB J. 2011;25:2911–20.
   PubMed Web of Science ®Google Scholar
• Wang J, Ho L, Chen L, Zhao Z, Zhao W, Qian X, et al. Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest. 2007;117:3393–402.
   PubMed Web of Science ®Google Scholar
• Gard PR, Rusted JM. Angiotensin and Alzheimer's disease: therapeutic prospects. Expert Rev Neurother. 2004;4:87–96.
   PubMedGoogle Scholar
• Choi DY, Lee JW, Lin G, Lee YK, Lee YH, Choi IS, et al. Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-kappa B signaling pathway. Neurochem Int. 2012;60:68–77.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Li XK, Cui X, Zuo PP. d-Galactose injured neurogenesis in the hippocampus of adult mice. Neurol Res. 2005;27:552–6.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xing Y, Ye CF, Ai HX, Wei HF, Li L. Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside. Behav Brain Res. 2006;173:246–54.
   PubMed Web of Science ®Google Scholar
• Cui X, Zuo P, Zhang Q, Li X, Hu Y, Long J, et al. Chronic systemic d-galactose exposure induces memory loss, neuro degeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid. J Neurosci Res. 2006;84:647–54.
   PubMed Web of Science ®Google Scholar
• Becaria A, Bondy SC, Campbell A. Aluminum and copper interact in the promotion of oxidative but not inflammatory events: implications for Alzheimer's disease. J Alzheimers Dis. 2003;5:31–8.
   PubMed Web of Science ®Google Scholar
• Kumar A, Prakash A, Dogra S. Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats. Pharmacol Rep. 2011;63:915–23.
   PubMed Web of Science ®Google Scholar
• Wang CQ, Yang GQ. Betacyanins from Portulaca oleracea L. ameliorate cognition deficits and attenuate oxidative damage induced by d-galactose in the brains of senescent mice. Phytomedicine. 2010;17:527–32.
   PubMed Web of Science ®Google Scholar
• Ravi SM, Prabhu BM, Raju TR, Bindu PN. Long-term effects of postnatal aluminium exposure on acetylcholinesterase activity and biogenic amine neurotransmitters in rat brain. Indian J Physiol Pharmacol. 2000;44:473–8.
   PubMedGoogle Scholar
• Kumar A, Prakash A, Dogra S. Naringin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress induced by d-galactose in mice. Food Chem Toxicol. 2010;48:626–32.
   PubMed Web of Science ®Google Scholar
• Hua X, Lei M, Ding H, Han Q, Hu G, Xiao M. Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with d-galactose: a potential contribution to Alzheimer's disease processes. Exp Neurol. 2008;210:709–18.
   PubMed Web of Science ®Google Scholar
• Tian J, Ishibashi K, Reiser K, Grebe R, Biswal S, Gehlbach P, et al. Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response. Proc Natl Acad Sci USA. 2005;102:11846–51.
   PubMed Web of Science ®Google Scholar
• Banks WA, Niehoff ML, Drago D, Zatta P. Aluminum complexing enhances amyloid beta protein penetration of blood–brain barrier. Brain Res. 2006;1116:215–21.
   PubMed Web of Science ®Google Scholar
• Ballard CG, Greig NH, Guillozet-Bongaarts AL, Enz A, Darvesh S. Cholinesterases: roles in the brain during health and disease. Curr Alzheimer Res. 2005;2:307–18.
   PubMedGoogle Scholar
• Zatta P, Ibn Lkhayat Idrissi M, Zambenedetti P, Kilyen M, Kiss T. In vivo and in vitro effects of aluminum on the activity of mouse brain acetylcholinesterase. Brain Res Bull. 2002;59:41–5.
   PubMed Web of Science ®Google Scholar
• Kaizer RR, Correa MC, Spanevello RM, Morsch VM, Mazzanti CM, Goncalves JF, et al. Acetylcholinesterase activation and enhanced lipid peroxidation after long-term exposure to low levels of aluminum on different mouse brain regions. J Inorg Biochem. 2005;99:1865–70.
   PubMed Web of Science ®Google Scholar
• Aliev G. Oxidative stress induced-metabolic imbalance, mitochondrial failure, and cellular hypoperfusion as primary pathogenetic factors for the development of Alzheimer disease which can be used as a alternate and successful drug treatment strategy: past, present and future. CNS Neurol Disord Drug Targets. 2011;10:147–8.
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Boyd Kimball D. Amyloid beta-peptide(1–42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathol. 2004;14:426–32.
   PubMed Web of Science ®Google Scholar
• Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr. 2000;71:621S–9S.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang A, Jiang B, Bao Y, Wang J, An L. Further pharmacological evidence of the neuroprotective effect of catalpol from Rehmannia glutinosa. Phytomedicine. 2008;15:484–90.
   PubMed Web of Science ®Google Scholar
• Qin Dl, Deng S, Zhang Z, Zhou M, Li H. Protective effect of valsartan or/and ligustrazine on hippocampal neuronal loss in rats with vascular dementia. Sichuan Da Xue Xue Bao Yi Xue Ban. 2011;42:56–100.
   PubMedGoogle Scholar
• Wakai T, Yoshioka H, Yagi T, Kato T, Kinouchi H. Effects of valsartan on neuroprotection and neurogenesis after ischemia. Neuroreport. 2011;22:385–90.
   PubMed Web of Science ®Google Scholar